News
Find out about what's been happening at the Clinic.
FutureMS: Fatigue in MS highlighted in recent publication
May 2025: Commentary in the Brain Communications journal highlights study on fatigue in early multiple sclerosis.
Revealing Hidden MS Symptoms Through a Health Comic
Apr 2025: Through the MS Looking Glass: Navigating the Unseen - MS awareness comic.
Belinda Weller Distinguished Lecture - event recording
Apr 2025: Watch a recording of the recent Belinda Weller Distinguished Lecture.
Building works at the Clinic
Apr 2025: We apologise for any inconvenience the current building works may cause.
Áine defends her PhD thesis
Apr 2025: Many congratulations to Dr Áine Heffernan who has successfully completed her PhD.
Octopus: clinical trial update
March 2025: Stage two of the Octopus Trial is open for recruitment at the Anne Rowling Clinic.
MS Research Meeting - event recording
Mar 2025: Watch a recording of our recent public event in which we gave an overview of some of the MS research studies ongoing at the Anne Rowling Clinic.
PhD congratulations to Dr Andrea Salzinger
Jan 2025: Many congratulations to Dr Andrea Salzinger who has successfully completed her PhD.
New funding for spinal cord imaging research study
Jan 2025: Congratulations to Dr Rozanna Meijboom and colleagues from the MS imaging group, who have recently been awarded funding for a research study to examine changes in the spinal cord of people with multiple sclerosis (MS).
Launch of NeuroCARE
Jan 2025: Our new platform for people in Scotland with a neurological condition, NeuroCARE, launched this month.
Competency Mapping for Neurology Specialist Nurses
Jan 2025: Anne Rowling Clinic nurses have helped develop a set of core competencies for neurology-based specialist nurses.
MS brain cell atlas paves the way for personalised treatments
Dec 2024: An international team including Anne Rowling Clinic researchers has published new research that separates people with MS into four different subgroups basd on what genes are active in brain cells. This paves the way for future personalised therapies.
